tirzepatide perimenopause Oova | Hormone Tracking for | A new Mayo Clinic led study found that postmenopausal women taking (an FDA-approved weight-loss medication) lost ~35% more GLP-1 use in menopause is

So the effects of GLP-1 agonists on periods are generally positive

Compliance will be key moving forward

Which antioxidants are safe and beneficial for egg and sperm quality

Manage Hypoglycemia : If you're at risk for low blood sugar, especially if taking insulin or other medications, monitor your levels closely and be aware of signs like dizziness or sweating

NDN Principal Investigator: Dr Tom Russ NDN Study Lead: Jessica Crossan To find out more about this research study, please contact: [email protected] 0131 537 3804

Womens Wellness Explained | Rosanna NP Womens health requires a nuanced understanding of hormonal shifts and metabolic needs